No association between rheumatoid arthritis, amyotrophic lateral sclerosis, and tumour necrosis factor inhibitor treatment

被引：3
|
作者：
Arkema, Elizabeth V. [1 ]
Feltelius, Nils [2 ,3 ]
Olsson, Tomas [4 ]
Askling, Johan [1 ,2 ]
机构：
[1] Karolinska Inst, Dept Med, Clin Epidemiol Unit, S-17176 Stockholm, Sweden
[2] Karolinska Inst, Dept Med, Rheumatol Unit, S-17176 Stockholm, Sweden
[3] Med Prod Agcy, Uppsala, Sweden
[4] Karolinska Inst, Dept Clin Neurosci, S-17176 Stockholm, Sweden
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷 / 11期
关键词：
TNF-ALPHA;
D O I：
10.1136/annrheumdis-2014-205622
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2061 / +
页数：2
相关论文
共 50 条
  • [41] Local versus Systemic Anti-Tumour Necrosis Factor-α Effects of Adalimumab in Rheumatoid Arthritis Pharmacokinetic Modelling Analysis of Interaction between a Soluble Target and a Drug
    Stepensky, David
    CLINICAL PHARMACOKINETICS, 2012, 51 (07) : 443 - 455
  • [42] Association of tumor necrosis factor alpha and IL-10 promoter polymorphisms with rheumatoid arthritis in North Indian population
    Deepali Gambhir
    Able Lawrence
    Amita Aggarwal
    Ramnath Misra
    Sudhir Kumar Mandal
    Sita Naik
    Rheumatology International, 2010, 30 : 1211 - 1217
  • [43] Association of tumor necrosis factor alpha and IL-10 promoter polymorphisms with rheumatoid arthritis in North Indian population
    Gambhir, Deepali
    Lawrence, Able
    Aggarwal, Amita
    Misra, Ramnath
    Mandal, Sudhir Kumar
    Naik, Sita
    RHEUMATOLOGY INTERNATIONAL, 2010, 30 (09) : 1211 - 1217
  • [44] Tumour necrosis factor alpha-driven IL-32 expression in rheumatoid arthritis synovial tissue amplifies an inflammatory cascade
    Heinhuis, Bas
    Koenders, Marije I.
    van Riel, Piet L.
    de Loo, Fons A. van
    Dinarello, Charles A.
    Netea, Mihai G.
    van den Berg, Wim B.
    Joosten, Leo A. B.
    ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (04) : 660 - 667
  • [45] Cardiovascular events and survival in rheumatoid arthritis: effects of anti-tumor necrosis factor-alpha treatment
    Cugno, Massimo
    TRANSLATIONAL RESEARCH, 2011, 157 (01) : 6 - 9
  • [46] Anti-tumour necrosis factor alpha therapy improves insulin sensitivity in normal-weight but not in obese patients with rheumatoid arthritis
    Stavropoulos-Kalinoglou, Antonios
    Metsios, Giorgos S.
    Panoulas, Vasileios F.
    Nightingale, Peter
    Koutedakis, Yiannis
    Kitas, George D.
    ARTHRITIS RESEARCH & THERAPY, 2012, 14 (04)
  • [47] Tumor necrosis factor-α blockade, cardiovascular outcomes, and survival in rheumatoid arthritis
    Al-Aly, Ziyad
    Pan, Hui
    Zeringue, Angelique
    Xian, Hong
    Mcdonald, Jay R.
    El-Achkar, Tarek M.
    Eisen, Seth
    TRANSLATIONAL RESEARCH, 2011, 157 (01) : 10 - 18
  • [48] Study on Tumor Necrosis Factor-alpha. Gene Polymorphism in Rheumatoid Arthritis
    Kyung-un, Kim
    Kyung-min, Lee
    Bong-hyo, Lee
    Seong-chul, Lim
    Tae-young, Jung
    Jung-chul, Seo
    JOURNAL OF PHARMACOPUNCTURE, 2007, 10 (02) : 73 - 79
  • [49] Anakinra: an inhibitor of IL-1 for the treatment of rheumatoid arthritis
    Fleischmann, R
    Stern, R
    Iqbal, I
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2004, 4 (08) : 1333 - 1344
  • [50] Weight loss and achievement of minimal disease activity in patients with psoriatic arthritis starting treatment with tumour necrosis factor α blockers
    Di Minno, Matteo Nicola Dario
    Peluso, Rosario
    Iervolino, Salvatore
    Russolillo, Anna
    Lupoli, Roberta
    Scarpa, Raffaele
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (06) : 1157 - 1162
12345